Mappa del sito
Site Map
- About Us
- Mission
- Departments
- National centres and Reference centres
- Clinical Governance
- Control and evaluation of medicines
- Dipendenze e doping
- Clinical excellence, healthcare quality and safety
- Rare diseases
- Gender medicine
- Notified body
- Disease prevention and health promotion
- Radiation protection and computational physics
- Drug research and evaluation
- HIV/AIDS research
- Global health
- Blood
- Behavioural sciences and mental health
- Water Safety (CeNSiA)
- Chemicals, cosmetics and consumer protection
- Animal research and welfare
- Innovative technologies in public health
- Telemedicine and new healthcare technologies
- Transplant
- Technical-scientific Services
- History
- Organization
- Single guarantee committee
- Regulations
- ISS staff
- Topics
- Nutrition and food safety
- Climate, environment and health
- Dependencies
- Medicines, vaccines and advanced therapies
- Fertility
- Gender and health
- Clinical governance, National guidelines system (SNLG) and HTA
- Health Professional Practice Assessment (HPPA)
- Hospital Based HTA
- Essential Assistance Levels (LEA)
- Evidence-based medicine
- Patient classification system
- National Guidelines System (SNLG)
- Health impact assessment
- Economic evaluation based on RWE, RCT and decision models
- Evaluation of drugs, devices, clinical procedures and care pathways
- Chronic diseases and aging
- Infectious diseases, HIV
- Neurological diseases
- Rare diseases
- Prevention and health promotion
- Radiation protection
- Protection from radon
- Protection from radioactivity in drinking water
- Protection from radioactivity in the enviroment, in dwelling and in workplaces
- Protection from (and optimized uso of) radiation in medicine
- Protection from radiation in nuclear and radiological emergencies
- Protection from non-ionizing radiation (electromagnetic fields, cell phones, 5G, UV)
- Women's, children's and adolescents' health
- Global health and health inequalities
- Mental health
- Biological basis of mental and behavioral disorders
- Psychological well-being and quality of life
- Neurodevelopmental disorders
- Psychiatric disorders
- Neurocognitive and psychic deficits in different stages of life
- Gene-environment interaction in mental health
- Pet therapy
- Personalized treatment in psychiatric disorders and neurodevelopment
- Veterinary public health
- Chemical substances and health protection
- Innovative technologies for health and telemedicine
- Tumors
- Activities
- Databases
- International collaborations
- INTERNATIONAL COLLABORATIONS
- WHO CC for Cystic and Alveolar Echinococcosis
- WHO CC for Environmental Health in Contaminated Sites
- Environment Health and Safety Programme of OECD
- The Environment Health and Safety Programme of OECD
- Context
- About us
- OECD Test Guidelines Programme
- Good practices in computational methods
- OECD activities of Working Party on Exposure Assessment – WPEA
- Per-and poly- fluorinated Chemicals (PFAS)
- Nanomaterials
- Novel foods and feeds
- Quantitative structure-activity relationship (QSAR)
- National Ethics Committee
- Training
- ISS-G20 Laboratorium
- Reference laboratories
- Laboratori di riferimento
- EURLP
- LNR per l'Escherichia-coli
- National Reference Laboratory on Food Contact Materials
- LNR per i metalli e i composti azotati negli alimenti
- LNR per gli additivi nei mangimi
- LNR per la caratterizzazione dei ceppi e la genetica delle EST degli animali
- LNR per i residui di farmaci veterinari in prodotti di origine animale
- National Reference Laboratory for pesticide residues in food products of animal origin and foods with a high fat content. (LNR-AO)
- LNR FV per residui di pesticidi in frutta e verdura, compresi alimenti ad alto contenuto di acqua (LNR-FV)
- National Reference Laboratory for pesticide residues: single residue methods (LNR-SRM)
- LNR per le micotossine e le tossine vegetali
- CNR per il botulismo
- LNR per i virus di origine alimentare
- LNR per i nanomateriali negli alimenti
- LNR per gli OGM
- LNR per il trattamento degli alimenti e dei loro ingredienti con radiazioni ionizzanti
- Guidelines - SNLG
- Museum
- Notified body
- Projects
- 3D Bioprinting di cute umana
- 90 anni ISS
- ARIANNA
- BioPlast4Safe
- EUROCARE
- IMMUNION
- Inibizione della GTPASI Umana
- Integratori e oncologia
- JAHEE
- La nanomedicina incontra le neuroscienze
- NAMS4NANO
- PartnERship to Contrast HPV (PERCH)
- Progetto ISS – PON
- Progetto NANOCELLUP
- Programma di formazione Salute-Ambiente-Biodiversità-Clima
- Pulvirus
- RL - Biodiversità vegetale per la produzione sostenibile di molecole
- RL - Elaborazione di dati clinici con metodologie di intelligenza artificiale
- RL - Fluorescent Nuclear Track Detector for Radiobiology - Biotrack
- RL - Life Science Excellence Hub – LSEH
- RL - NBP - Neuro Brain Platform
- RL - Sanificazione ad alta pressione delle acque con rimozione e monitoraggio di patogeni (HPSWFood)
- Sviluppo di nanosistemi
- TRUST-ME
- Publications
- Registers and surveillance
- Networks
- School
- Servizio Civile Universale
- Phase 1 clinical trials
- Services and Utilities
- Meeting rooms
- Calls and competitions
- Library
- Patronage
- Intellectual property
- Fares and paid services
- Publications
- Publications
- Annali
- Bollettino epidemiologico nazionale
- Notiziario
- Rapporti ISTISAN
- Rapporti ISS Sorveglianza
- ISS Activity Reports
- ISS policy documents
- Monographs
- ISTISAN Congressi
- Strumenti di riferimento
- Rapporti ISS COVID-19
- Rapporti ISS COVID-19 in English
- Rapporti ISS COVID-19 en Español
- Beni storico-scientifici
- Dispense per la scuola
- Consensus ISS
- Leaflets
- Historical videos
- Ceased publications
- Press Room
- Home Page
- About us
- Press notes
- News
- Press releases
- Press review
- Special on COVID-19
- Varianti del virus
- Vaccini
- Cosa sapere
- Documenti in rilevo
- Consulta i dati
- Modalità accesso ai dati
- Sorveglianze Covid-19
- Long COVID
- Events
- Digitale
- Events
- ISSalute
- Transparent administration
- Tender notices
- Data protection
